Actively Recruiting
ADHERE Trial: Strategies to Improve Mobile App Adherence
Led by Neuroscience Research Australia · Updated on 2026-01-14
258
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the effectiveness of two communication interventions, compared to standard app notifications, in increasing adherence to a mobile health app among individuals with chronic low back pain. The main question it aims to answer is: Do phone calls or text messages increase adherence compared to app notifications in patients receiving a digital health intervention for chronic back pain? Participants will: A) Receive pain education and clinical hypnosis via a mobile app for managing chronic LBP; B) Will be contacted up to twice via phone call or text message, or they will only receive standard notifications from the app.
CONDITIONS
Official Title
ADHERE Trial: Strategies to Improve Mobile App Adherence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Experiencing non-specific chronic low back pain, defined as pain between the 12th rib and the buttock crease
- Low back pain with or without leg pain, where back pain is worse than leg pain
- Currently consulting with a general practitioner for non-specific chronic low back pain in Australia
- Mean pain intensity score of 3 or higher out of 10 in the past week
- At least moderate physical functioning score on question 8 of the SF-36 questionnaire
- Access to a mobile device that can download the study app (requires 300MB)
- Access to an internet connection to use the app's functions
- Able to understand English through reading and audio materials
- Randomised to experimental group in the NOTUS Trial
You will not qualify if you...
- Known or suspected specific spinal problems like radiculopathy or fracture
- Known or suspected non-spinal problems like tumor or infection
- Less than six months since spinal surgery
- Scheduled for major surgery during the study or follow-up period
- Known or suspected serious psychiatric conditions not treated by a health professional that would affect participation
- Known or suspected sight or hearing problems limiting use of reading or audio components with headphones
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Neuroscience Research Australia
Sydney, New South Wales, Australia, 2031
Actively Recruiting
Research Team
J
James H McAuley, PhD
CONTACT
R
Rodrigo RN Rizzo, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here